Results 21 to 30 of about 10,600 (216)

Neutropenia as an adverse event following vaccination : results from randomized clinical trials in healthy adults and systematic review [PDF]

, 2016
Background : In the context of early vaccine trials aimed at evaluating the safety profile of novel vaccines, abnormal haematological values, such as neutropenia, are often reported.
Aerssens, Annelies, Anemona, Alessandra, Bodinham, Caroline L, Groth, Nicola, Launay, Odile, Leroux-Roels, Geert, Lewis, David, Loulergue, Pierre, Muturi-Kioi, Vincent, Podda, Audino, Saul, Allan   +10 more
core   +10 more sources

Recombinant Zoster Vaccine Associated with a Reduced Risk of Dementia Onset among US Beneficiaries ≥65 Years of Age [PDF]

Alzheimers Dement
Abstract Background Research showing lower risk of all‐cause dementia, Alzheimer’s Disease (AD), and vascular dementia (VD) with herpes zoster vaccination was based on one vaccine no longer marketed in the US. We evaluated the risk of dementia among US Medicare beneficiaries ≥65 years‐old who received recombinant zoster vaccine (RZV) relative to ...
dosReis S, Tran P, Mohanty K, Amill‐Rosario A, Johnson A, Ryan K, Alsdurf H, Oraichi D, Pinto S, Yun H.   +9 more
europepmc   +2 more sources

Position paper of the Italian College of Rheumatologists (CReI) on herpes zoster vaccination [PDF]

Beyond Rheumatology, 2022
Herpes Zoster (HZ) is a blistering, painful and disabling cutaneous rash that can occur in any type of patient at any age. It is caused by reactivation of the Varicella Zoster Virus (VZV).
D. Marotto, P. Sarzi-Puttini, V. Giorgi, M. Benucci, A. Migliore, P. Amato, A. Riva   +6 more
doaj   +1 more source

Vaccines for prophylaxis of viral infections in patients with hematological malignancies. [PDF]

, 2011
Viral infections cause significant morbidity and mortality in patients with hematological malignancies. It remains uncertain whether viral vaccinations in these patients are supported by good evidence.
Chan, GC, Cheuk, DK, Chiang, AK, Ha, SY, Lee, TL   +4 more
core   +1 more source

Vaccination in Kidney Transplant Candidates

Transplantation Direct, 2023
Background:. Kidney transplant (KT) candidates have historically low immunization rates against recommended vaccines. A retrospective single-center study of contemporary KT candidates was conducted to assess vaccination rates and vaccine uptake. Methods:.
Kiran Gajurel, MD, Tue Ngo, MD, MPH, Robert T. Fairman, PhD, MPH, Lewis H. McCurdy, MD   +3 more
doaj   +1 more source

High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia [PDF]

, 1998
A survey for antibodies to a recombinant small viral capsid antigen (sVCA) of human herpesvirus type 8 (HHV‐8) was conducted in Sardinia, one of the world's highest incidence areas for classic Kaposi's sarcoma (KS). Prevalence of antibodies to HHV‐8 sVCA
Angeloni, Antonio, Cerimele, Decio, Cottoni, Francesca Maria Giovanna, Faggioni, Alberto, Heston, Lee, Lin, Su-Fang, Masala, Maria Vittoria, Miller, George, Rigsby, Michael, Sirianni, Maria Caterina, Sun, Ren, Uccini, Stefania   +11 more
core   +1 more source

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster

Human Vaccines & Immunotherapeutics, 2023
Herpes zoster (HZ) results from waning immunity following childhood infection with varicella zoster virus (VZV) but is preventable by vaccination with recombinant HZ vaccine or live HZ vaccine (two doses or one dose, respectively).
Marta Ulaszewska, Sarah Merelie, Sarah Sebastian, Teresa Lambe   +3 more
doaj   +1 more source

Varicella Zoster vaccination in hemodialysis patients: The state of the art

Human Vaccines & Immunotherapeutics, 2023
Varicella Zoster Virus (VZV) infection is a common childhood exanthematous disease, which in adults and immunocompromised people may result in severe neurologic complications.
Laura Gobbi, Francesca Katiana Martino, Elena Sgrò, Federico Nalesso, Lorenzo A. Calo’   +4 more
doaj   +1 more source

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine [PDF]

The Journal of Infectious Diseases, 2020
Abstract Background Efficacy of the live-attenuated herpes zoster (HZ) vaccine (ZVL) wanes substantially over time. We evaluated immunogenicity and safety of the adjuvanted recombinant zoster vaccine (RZV) in previous ZVL recipients. Methods
Alemnew F Dagnew, Nicola P Klein, Caroline Hervé, George Kalema, Emmanuel Di Paolo, James Peterson, Bruno Salaun, Anne Schuind   +7 more
openaire   +2 more sources

Risk of Herpes Zoster in Individuals on Biologics, DMARDS and/or Corticosteroids for Autoimmune Diseases:A Systematic Review and Meta-Analysis [PDF]

, 2016
Background: Studies examining the risk of herpes zoster (HZ) associated with immunosuppressants, such as biologics, non-biological disease modifying agents (nbDMARDs) or corticosteroids, have generated conflicting results.
Alarcón-Segovia, Bachelez, Bejarano, Bongartz, Braun, Brenner, Bresnihan, Cardiel, Che, Chen, Choy, Cohen, Cutolo, Dechartres, Dixon, Dixon, Dreiher, Egger, Emery, Emery, Fleischmann, Fleischmann, Furie, Furst, Galloway, Genovese, Genovese, Gupta, Gupta, Harpaz, Hayward, Higgins, Higgins, Hoes, Kameda, Kawai, Keystone, Kost, Kourbeti, Kremer, Kremer, Kremer, Kremer, Lal, Leonardi, Long, McDonald, Merrill, Moher, Moreland, Moutsopoulos, Nakajima, Nishimoto, Osterman, Oxman, Oxman, Papp, Pappas, Peto, Rutgeerts, Sampathkumar, Sandborn, Sandborn, Schiff, Schreiber, Segan, Shah, Singh, Smitten, Smolen, Smolen, Spittal, Strangfeld, Stroup, Sweeting, Takeuchi, Tanaka, Tanaka, van der Heijde, van Vollenhoven, Veetil, Weiner, Wells, Winthrop, Winthrop, Winthrop, Wolfe, Yamamoto, Yawn, Yawn, Youssef, Yun, Zhang, Zisman, Zorzela   +94 more
core   +1 more source